Oncolytics Biotech, Inc. (ONCY)
0.9856
+0.01
(+0.90%)
USD |
NASDAQ |
Dec 10, 16:00
0.9962
+0.01
(+1.08%)
After-Hours: 19:46
Oncolytics Biotech EPS Diluted (Quarterly): -0.1032 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.2491 |
| Lexaria Bioscience Corp. | -0.1378 |
| Xenon Pharmaceuticals, Inc. | -1.147 |
| ProMIS Neurosciences, Inc. | -0.2371 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.46M |
| Total Expenses (Quarterly) | 10.46M |
| Enterprise Value | 95.41M |
| Earnings Yield | -28.52% |
| Normalized Earnings Yield | -27.95 |